31 studies found for:    Open Studies | "Ureteral Diseases"
Show Display Options
Rank Status Study
1 Recruiting Dismembered Pyeloplasty With and Without After Coming Stent
Conditions: Pelviureteric Junction Obstruction;   Pyeloplasty;   Neonate Affected by Hydronephrosis;   Obstructive Uropathy;   Urinary Stent
Interventions: Procedure: After coming stent after dismembered pyeloplasty;   Procedure: Stentless dismembered pyeloplasty
2 Unknown  A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Family Members
Conditions: Kidney Neoplasm;   Kidney Stone;   Ureteral Tumor;   Ureteral Stricture;   Renal Insufficiency
Intervention: Procedure: Restored Kidney Transplant Between Family Members
3 Recruiting Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer;   Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter;   Proximal Urethral Cancer;   Recurrent Bladder Cancer;   Recurrent Prostate Cancer;   Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter;   Recurrent Urethral Cancer;   Regional Transitional Cell Cancer of the Renal Pelvis and Ureter;   Stage IV Bladder Cancer;   Stage IV Prostate Cancer;   Stage IV Urethral Cancer;   Transitional Cell Carcinoma of the Bladder;   Ureter Cancer;   Urethral Cancer Associated With Invasive Bladder Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: cisplatin;   Other: placebo;   Biological: bevacizumab;   Other: laboratory biomarker analysis
4 Unknown  Comparing Patients After ESWL Treated With Ureteral Stents Versus Expulsion Therapy With Tamsulosin
Condition: Upper Tract Ureterolithiasis
Intervention: Drug: Tamsulosin
5 Recruiting Laparoscopic Pyeloplasty Registry and Database
Condition: Ureteral Obstruction
Intervention: Other: Registry and database
6 Not yet recruiting Trial Comparing Relapse Rates Between Standard Ureteroscopic Removal Of Ureteral Stone And Standard Removal With Additional Ureterorenic Clearing Of Non-Symptomatic Stones In The Kidney
Condition: Ureteral Stones
Interventions: Procedure: Ureteral stone removal;   Procedure: Asymptomatic kidney stones and ureteral stone removed
7 Recruiting Evaluating Ureteral Length Using Computed Tomography (CT)
Conditions: Ureteral Calculi;   Hydronephrosis;   Ureteral Obstruction
Intervention: Device: Ureteral catheterization - Cook Urological Inc. open end ureteral catheter 5FR
8 Unknown  Does Treatment With Alfuzosin Increase Success Rates of (SWL) Shock Wave Lithotripsy
Conditions: Urolithiasis;   Nephrolithiasis;   Ureterolithiasis
Interventions: Drug: Alpha blocker-alfuzosin;   Drug: placebo
9 Recruiting Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Conditions: Bladder Cancer;   Breast Cancer;   Endometrial Cancer;   Esophageal Cancer;   Head and Neck Cancer;   Lung Cancer;   Melanoma;   Ovarian Neoplasm;   Testicular Lymphoma;   Transitional Cell Cancer of the Renal Pelvis and Ureter;   Unspecified Adult Solid Tumor, Protocol Specific;   Ureter Cancer;   Urethral Cancer
Interventions: Drug: veliparib;   Drug: paclitaxel;   Drug: carboplatin;   Other: laboratory biomarker analysis;   Other: pharmacological study
10 Unknown  Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer
Conditions: Bladder Cancer;   Transitional Cell Cancer of the Renal Pelvis and Ureter;   Urethral Cancer
Interventions: Drug: sunitinib malate;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: quality-of-life assessment
11 Unknown  Alfuzosin for Medical Expulsion Therapy of Ureteral Stones
Condition: Kidney Stones
Interventions: Drug: Alfuzosin;   Drug: nifedipine;   Drug: doxazosin;   Drug: prazosin
12 Unknown  Comparative Treatment Study in Patients With Lower Ureteral Stones
Condition: Urinary Calculi
Intervention:
13 Recruiting Cabozantinib for Advanced Urothelial Cancer
Conditions: Urethral Neoplasms;   Ureteral Neoplasms;   Urinary Bladder Neoplasms;   Kidney Neoplasms
Intervention: Drug: Cabozantinib
14 Unknown  Shockwave Lithotripsy (SWL) Under Selective, General Anesthesia.
Conditions: Renal Calculi;   Ureteral Calculi
Intervention:
15 Recruiting Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
Conditions: Distal Urethral Cancer;   Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter;   Proximal Urethral Cancer;   Recurrent Bladder Cancer;   Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter;   Recurrent Urethral Cancer;   Regional Transitional Cell Cancer of the Renal Pelvis and Ureter;   Stage III Bladder Cancer;   Stage III Urethral Cancer;   Stage IV Bladder Cancer;   Stage IV Urethral Cancer;   Ureter Cancer;   Urethral Cancer Associated With Invasive Bladder Cancer
Interventions: Drug: eribulin mesylate;   Other: laboratory biomarker analysis;   Other: pharmacological study
16 Unknown  Use of the PercSys MicroStent Device to Alleviate Ureteral Stone Symptoms and Hydronephrosis
Condition: Kidney Stones
Intervention:
17 Not yet recruiting Sterile Water Injections for Relieving Ureterolithiasis Pain
Conditions: Ureterolithiasis;   Pain
Interventions: Other: Diclofenac and sterile water injections;   Other: Diclofenac and isotonic saline
18 Unknown  The Use of Medical-Expulsive Therapy With Alfuzocine xl 10mg x1/d for Distal Ureterolithiasis.a Randomized Prospective Study
Condition: Distal Ureterolithiasis
Intervention: Drug: Alfuzocine XL 10 mg once a day
19 Recruiting Feasibility Study of the Uriprene Stent Following Uncomplicated Ureteroscopy
Conditions: Unilateral Ureteral Stone;   Renal Stone Fragments ≤ 2mm
Intervention: Device: Post-Ureteroscopy ADVA-Tec Uriprene™ Degradable Temporary Ureteral Stent
20 Recruiting Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer
Conditions: Bladder Cancer;   Transitional Cell Cancer of the Renal Pelvis and Ureter;   Ureter Cancer;   Urethral Cancer
Interventions: Drug: carboplatin;   Drug: gemcitabine hydrochloride;   Drug: vandetanib;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results
Indicates status has not been verified in more than two years